EMOA : 160405- Emotra- PM- Documents for AGM

Kallelse

Press release from Emotra AB (publ)

Göteborg, April 5, 2016

Documents prepared for the Annual General Meeting The Company's annual financial statement for the financial year 2015, as well as other documents required for the annual meeting, are available from the Company's web site (www.emotra.se) as of today, and are also provided upon request by the Company (see address below).

The shareholders are hereby informed of their right, in accordance with the Companies act, to request information at the annual meeting about circumstances that could affect the judgement of an item on the agenda, as well as any circumstances that could affect the judgement of the Company's financial standing.

Emotra's AGM

The annual meeting of shareholders in Emotra AB (publ) will be held at 4:00 pm on April 26, 2016, at the

restaurant John Scott´s Pub, with the address Kungsportsavenyn 15 in Göteborg, Sweden.

Registration

Shareholders who wish to participate in the annual meeting must be registered in the shareholder ledger that is managed by Euroclear Sweden AB by Wednesday April 20, 2016, as well as register their intent to participate by post sent to the Company at the following address: Emotra AB, Göteborgsvägen 74, SE-433 63 Sävedalen, Sweden, by telephone at +46 708 25 45 47 or by e-mail to claes@emotra.se no later than Friday April 22, 2016.

When registering, please provide the following information: name, number of shares held, personal

/corporate identity number, address and daytime telephone number as well as details about any accompanying counsel. Originals of any proxy letters, as well as certificate(s) of registration, should be sent to the Company by post to the above address well in advance of the meeting. Shareholders whose shares are held in the trust department of a bank or by a brokerage firm must have their shares temporarily re-registered in their own name well in advance of the annual meeting.

Göteborg in April, 2016 EMOTRA AB

Board of Directors

For further information, please contact:

Claes Holmberg, CEO, telephone: +46 708 25 45 47, E-mail: claes@emotra.se

Emotra AB (publ) is a medical technology company that carries out research, development, clinical studies and marketing in the area of suicide prevention. The Company's method, EDOR™, is a proprietary, objective and quantitative diagnostic, psychophysiological test for detecting hyporeactivity in patients suffering from depression. During the test, the patient listens to a series of audio signals. The patient's response, in the form of very small changes in dermal electric conductivity, is measured and analysed. This extremely sensitive and specific test of suicidal risk has been developed as the result of research.

Emotra AB (publ), Göteborgsvägen 74, SE-433 63 Sävedalen, Sweden Tel: +46 708 25 45 47, www.emotra.se